Table 2 Demographic and symptom data for HCW cohort at 12 months after SARS-CoV-2 infection
SARS-CoV-2 infection naive | SARS-CoV-2 infection (First UK wave) Recovered | SARS-CoV-2 infection (First UK wave) Persistent symptoms | p value Chi squared (Bonferroni corrected) Symptom frequency infection naive vs infected | |
|---|---|---|---|---|
HCW: n (%) | 271 (76) | 61 (17) | 25 (7) | |
Mean age: years (range) | 40 (18–69) | 42 (21–62) | 39 (25–59) | |
Female: n (%) | 178 (66) | 40 (66) | 18 (72) | |
Male: n (%) | 93 (34) | 21 (34) | 7 (28) | |
Ethnicity: | ||||
White: n (%) | 192 (71) | 48 (79) | 17 (68) | |
Minority ethnic group (UK): n (%) | 79 (29) | 13 (21) | 8 (32) | |
Persistent symptom(s): n (%) | ||||
Anxiety | 7 (2.7) | 0 (0) | 11 (44) | 0.0046 |
Sore throat | 0 (0) | 0 (0) | 3 (12) | 0.0046 |
Low mood | 9 (3.4) | 0 (0) | 10 (40) | 0.0644 |
Insomnia | 5 (1.9) | 0 (0) | 9 (36) | 0.0069 |
Headache | 10 (3.8) | 0 (0) | 10 (40) | 0.1219 |
Pins and Needles | 3 (1.1) | 0 (0) | 4 (16) | 0.8947 |
Confusion | 4 (1.5) | 0 (0) | 2 (8) | 1.0 |
Fainting | 2 (0.7) | 0 (0) | 0 (0) | 1.0 |
Dizziness | 4 (1.5) | 0 (0) | 4 (16) | 1.0 |
Weight loss | 7 (2.7) | 0 (0) | 0 (0) | 1.0 |
Loss of appetite | 3 (1.1) | 0 (0) | 1 (4) | 1.0 |
Abdominal pain | 3 (1.1) | 0 (0) | 1 (4) | 1.0 |
Nausea or vomiting | 2 (0.7) | 0 (0) | 0 (0) | 1.0 |
Constipation | 1 (0.4) | 0 (0) | 3 (12) | 0.3818 |
Diarrhoea | 0 (0) | 0 (0) | 1 (4) | 1.0 |
Fatigue | 9 (3.4) | 0 (0) | 18 (72) | 0.0023 |
Joint ache or swelling | 6 (2.3) | 0 (0) | 8 (32) | 0.0736 |
Muscle aches | 8 (3.0) | 0 (0) | 8 (32) | 0.3013 |
Palpitations | 4 (1.5) | 0 (0) | 4 (16) | 1.0 |
Pain on breathing | 0 (0) | 0 (0) | 1 (4) | 1.0 |
Shortness of breath | 5 (1.9) | 0 (0) | 10 (40) | 0.0023 |
Chest tightness | 3 (1.1) | 0 (0) | 1 (4) | 1.0 |
Cough | 2 (0.7) | 0 (0) | 2 (8) | 1.0 |
